In the complex world of pharmaceutical development, certain chemical compounds stand out for their critical roles in life-saving therapies. Plerixafor, identified by CAS number 155148-31-5, is one such compound. As a specialized pharmaceutical intermediate, Plerixafor plays a pivotal role in advanced medical treatments, particularly in the field of stem cell transplantation. Understanding its applications, sourcing requirements, and benefits is crucial for procurement managers, R&D scientists, and formulation specialists in the pharmaceutical and biotech industries.

What is Plerixafor?

Plerixafor is primarily known for its function as a hematopoietic stem cell mobilizer. It works by inhibiting the CXCR4 chemokine receptor, which in turn blocks the binding of its ligand, stromal cell-derived factor-1α (SDF-1α). This interaction is fundamental in the homing and retention of hematopoietic stem cells (HSCs) within the bone marrow. By disrupting this process, Plerixafor effectively encourages the release of HSCs into the peripheral bloodstream. This makes them available for collection and subsequent autologous transplantation, a common procedure for patients undergoing treatment for certain types of cancer, such as non-Hodgkin's lymphoma and multiple myeloma.

Key Applications in Pharmaceutical Manufacturing

The primary application for Plerixafor as a pharmaceutical intermediate lies in its role in stem cell mobilization. When administered in conjunction with other growth factors like filgrastim, Plerixafor significantly enhances the yield of HSCs. This improved mobilization is critical for ensuring that patients receive an adequate number of stem cells for successful transplantation, leading to better treatment outcomes and recovery rates. For companies seeking to buy Plerixafor pharmaceutical intermediate, securing a consistent supply of high-purity material is paramount. We pride ourselves on being a reliable Plerixafor manufacturer in China, offering material with a 99% minimum purity, ensuring it meets the rigorous standards required for pharmaceutical use.

Why Source Plerixafor from a Trusted Supplier?

Procuring pharmaceutical intermediates like Plerixafor requires a deep understanding of quality, consistency, and regulatory compliance. As a leading Plerixafor supplier, we are committed to providing products that meet global pharmaceutical standards. Our manufacturing processes are designed to ensure the highest purity and a stable supply chain, which is vital for our clients who depend on this critical ingredient for their therapeutic formulations. Understanding the market demand, we aim to offer competitive Plerixafor prices, making it accessible for research and large-scale manufacturing. If you are looking to purchase Plerixafor, consider partnering with a manufacturer that prioritizes quality and customer satisfaction.

The Importance of Purity and Specification

In the pharmaceutical industry, the purity of intermediates directly impacts the safety and efficacy of the final drug product. Plerixafor, with its specific CAS number 155148-31-5, must meet precise specifications. Our commitment to excellence means that every batch of Plerixafor we produce undergoes rigorous quality control testing. This attention to detail ensures that our clients receive a product that is not only effective but also safe for its intended medical applications. Whether for research purposes or bulk manufacturing, specifying a trusted Plerixafor CAS 155148-31-5 supplier is the first step towards a successful project.

For companies requiring high-quality Plerixafor, we offer a reliable source. Our expertise as a manufacturer and supplier allows us to meet diverse client needs, from sample requests for R&D to large-volume orders for production. Engage with us to discuss your requirements and discover how our Plerixafor can support your pharmaceutical innovation.